Floatz logo

FLUDROCORTISONE

Advanced Metastatic Castration Resistant Prostate Cancer

Acerand Therapeutics (Hong Kong) LimitedSmall moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Advanced Metastatic Castration Resistant Prostate Cancer cohort.

Asset / SponsorPhaseRating
Inv-9956
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2CCC

Same molecule, other indications

FLUDROCORTISONE is also rated in:

congenital adrenal hyperplasiaDormant
BB
Indicative ·
69 / 100
View asset →
Parkinson diseaseDormant
BB
Indicative ·
64 / 100
View asset →
TraumaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →